Abstract

BackgroundPatients with end-stage renal disease have very high mortality. In individuals on hemodialysis, cardiovascular deaths account for ~50% of all deaths in this population, mostly due to arrhythmia. To determine the causes of these arrhythmic deaths is essential in order to adopt preventive strategies. The main objective of this study was to investigate whether, the presence of QTc interval alterations, from electrolyte abnormalities or presence of rare genetic variants, could have a relationship with sudden arrhythmogenic deaths in end-stage renal disease patients.MethodsWe recorded the pre- and post-dialysis QTc interval in 111 patients undergoing hemodialysis. In 47 of them, we analyzed 24 SCD-related genes including the most prevalent genes associated with long QT syndrome using a custom resequencing panel.ResultsWe found a positive although not significant association between the presence of long QTc and mortality in a subset of end-stage renal disease patients. In addition, in five patients with long QTc only after dialysis (21.7%) we detected rare potentially pathogenic genetic variants. Three out of these five carriers subsequently died suddenly.ConclusionsGenetic background may be determinant in the risk of sudden cardiac death in these patients. We recommend evaluating the QTc interval before and after hemodialysis, and performing a genetic analysis of individuals with long QTc after hemodialysis.

Highlights

  • Chronic kidney disease (CKD), defined as either kidney damage or glomerular filtration rate (GFR) below 60ml/min/1.73m2 for ! 3 months[1], is a very relevant health entity

  • We found a positive not significant association between the presence of long QTc and mortality in a subset of end-stage renal disease patients

  • Genetic background may be determinant in the risk of sudden cardiac death in these patients

Read more

Summary

Introduction

Chronic kidney disease (CKD), defined as either kidney damage or glomerular filtration rate (GFR) below 60ml/min/1.73m2 for ! 3 months[1], is a very relevant health entity. CKD has a prevalence of 4.7–8.1% in people ages 60 and older and of 0.5%, in the population between the ages of 20 and 39 years of age [2, 3]. People with CKD are at higher mortality risk compared with the general population. Cardiovascular deaths (CD) account for ~50% of all deaths in CKD, in individuals on hemodialysis (HD)[4]. Most cardiovascular deaths in this patient population involves arrhythmic mechanisms[5]. Patients with end-stage renal disease have very high mortality. Cardiovascular deaths account for ~50% of all deaths in this population, mostly due to arrhythmia. The main objective of this study was to investigate whether, the presence of QTc interval alterations, from electrolyte abnormalities or presence of rare genetic variants, could have a relationship with sudden arrhythmogenic deaths in end-stage renal disease patients

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call